Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Breviscapine effect on cytochrome P450 enzymes and P-glycoprotein in healthy volunteers
ChiCTR-IPR-16009366Phase 4Recruiting
- Sponsor
- Dali University
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Dengzhanxixin (6 arms), sponsored by Dali University. Primary endpoints: Plasma concentrations of fexofenadine, Plasma concentrations of losartan and E3174 and 1 more. Started Oct 2016; status: recruiting.
02
Drugs
Dengzhanxixin
Beyond the preview
Go deeper on ChiCTR-IPR-16009366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009366.